Выбор редакции

Valeant bids US$5.7b to buy Cephalon

CANADIAN drug maker Valeant Pharmaceuticals International said it made an unsolicited US$5.7 billion bid to buy Cephalon Inc and plans to make its case directly to Cephalon shareholders.

Valeant, formed when Canada's...
НОВОСТИ ПО ТЕМЕ